Renexxion goes to FDA with cystic fibrosis drug
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food…
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food…
OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project…
Research led by RCSI University of Medicine and Health Sciences in Ireland has discovered three…
RCSI University of Medicine and Health Sciences and FutureNeuro are co-leading, with University College Dublin,…
EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive…
Priothera, a biotechnology company developing its S1P receptor modulator compound Mocravimod, has announced that positive…
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and…
Poolbeg Pharma has signed an exclusive agreement with University College Dublin (UCD) through NovaUCD, the…
SynOx Therapeutics Limited says its novel monoclonal antibody, emactuzumab, in development for the treatment of…
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…